RxAll is an AI-hyperspectral
Platform for Authenticating Medicines.
Our platform uses a proprietary molecular sensor device with a cloud-based IP-protected AI algorithm and database of spectral signatures of medicines to carry out non-destructive pill authentication.

We work with pharma manufacturers and their partners to reduce branded drug counterfeiting and ensure that patients receive high quality authenticated medicines. Pharma manufacturers increase sales and patients have better access to high quality medicines.

We are expanding our business in Southeast Asia, Africa and Latin America. We are currently operational in Singapore, Malaysia, Kenya and Nigeria.

Users will find RxAll’s technology unique as it aims to assure the quality of medicines delivered to patients in growth countries.